GO321
/ GeneSail Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 06, 2026
A Clinical Study of GO321 in Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=21 | Not yet recruiting | Sponsor: GeneSail Biotech (Shanghai) Co., Ltd.
IO biomarker • New P1 trial • Gastrointestinal Cancer • Oncology • Ovarian Cancer • Solid Tumor
1 to 1
Of
1
Go to page
1